the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
[0064] Preparation method: Take L-glutamic acid and sorbic acid, add them to 68.5kg of water for injection, heat to 85°C, add hypromellose, stir evenly, add palmatine, stir evenly, add 2.4kg of water for injection, Stir and cool down to room temperature, and fill to obtain 10,000 gels.
Embodiment 2
[0066] Palmatine Press C 21 h 21 NO 4 ·HCl·3H 2 O is 500g, hypromellose 1500g, L-glutamic acid 16.2g, sorbic acid 48.8g.
[0067] Preparation method: Take L-glutamic acid and sorbic acid, add them to 68.5kg of water for injection, heat to 85°C, add hypromellose, stir evenly, add palmatine, stir evenly, add 2.4kg of water for injection, Stir and cool down to room temperature, and fill to obtain 10,000 gels.
Embodiment 3
[0069] Palmatine Press C 21 h 21 NO 4 ·HCl·3H 2 O is 500g, hypromellose 1500g, L-glutamic acid 18.6g, sorbic acid 46.4g.
[0070] Preparation method: Take L-glutamic acid and sorbic acid, add them to 68.5kg of water for injection, heat to 85°C, add hypromellose, stir evenly, add palmatine, stir evenly, add 2.40kg of water for injection, Stir and cool down to room temperature, and fill to obtain 10,000 gels.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention belongs to the technical field of medicines, and discloses a medicine composition containing palmatine. The medicine composition comprises palmatine, hydroxypropyl methylcellulose, ethylparaben and a pH regulator. The invention further discloses another medicine composition containing palmatine. The medicine composition comprises palmatine, hydroxypropyl methylcellulose, sorbic acid and L-glutamic acid. Tests indicate that vaginal gel prepared from the medicine composition has better safety and stability.
Description
technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a pharmaceutical composition containing palmatine. Background technique [0002] Vulvovaginal candidiasis (VVC) is a common multiple vulvovaginal inflammatory disease caused by Candida. Candida albicans is an opportunistic pathogen. 10% to 20% of non-pregnant women and 30% of pregnant women have this bacteria in the vagina, but the amount of bacteria is small and does not cause symptoms. Only when the systemic and local immunity of the vagina is weakened, especially the local cellular immunity, and Candida albicans multiply in large numbers, will it cause vaginitis symptoms. The pathogenesis of the disease is: Candida is a fungus, and what usually causes vaginitis is Candida albicans in Candida. Candida is not very resistant to heat, and can die after being heated to 60°C for an hour. But it is more resistant to drying, sunlight, ultraviolet rays and chemical agen...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.